The Wall Street Journal: FDA investigating cause of bad batch of Johnson & Johnson COVID-19 vaccine


The Food and Drug Administration is investigating what caused a batch of the active ingredient for Johnson & Johnson’s COVID-19 vaccine to be scrapped for failing to meet quality standards at a contract manufacturing plant, according to a person familiar with the matter.

Asia Markets: Stocks rise in Japan and China; most other major markets closed for holiday

Previous article

The Moneyist: My aunt took over from me as my grandmother’s power of attorney and executor of my grandfather’s $1.3 million estate. Should I retaliate?

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News